Literature DB >> 31215803

Urinary dysfunction in transgenic sickle cell mice: model of idiopathic overactive bladder syndrome.

Serkan Karakus1, Uzoma A Anele1,2, Fábio H Silva1,3, Biljana Musicki1, Arthur L Burnett1.   

Abstract

Voiding abnormalities are common among the sickle cell disease (SCD) population, among which overactive bladder (OAB) syndrome is observed at rates as high as 39%. Although detrusor overactivity is the most common cause of OAB, its molecular pathophysiology is not well elucidated. The nitric oxide (NO) signaling pathway has been implicated in the regulation of lower genitourinary tract function. In the present study, we evaluated the role of the NO signaling pathway in voiding function of transgenic SCD mice compared with combined endothelial and neuronal NO synthase gene-deficient mice, both serving as models of NO deficiency. Mice underwent void spot assay and cystometry, and bladder and urethral specimens were studied using in vitro tissue myography. Both mouse models exhibited increased void volumes; increased nonvoiding and voiding contraction frequencies; decreased bladder compliance; increased detrusor smooth muscle contraction responses to electrical field stimulation, KCl, and carbachol; and increased urethral smooth muscle relaxation responses to sodium nitroprusside compared with WT mice. In conclusion, our comprehensive behavioral and functional study of the SCD mouse lower genitourinary tract, in correlation with that of the NO-deficient mouse, reveals NO effector actions in voiding function and suggests that NO signaling derangements are associated with an OAB phenotype. These findings may allow further study of molecular targets for the characterization and evaluation of OAB.

Entities:  

Keywords:  cystometry; detrusor overactivity; nitric oxide; voiding dysfunction; voiding spot

Year:  2019        PMID: 31215803      PMCID: PMC6766627          DOI: 10.1152/ajprenal.00140.2019

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  50 in total

1.  Urothelial pathophysiological changes in feline interstitial cystitis: a human model.

Authors:  J P Lavelle; S A Meyers; W G Ruiz; C A Buffington; M L Zeidel; G Apodaca
Journal:  Am J Physiol Renal Physiol       Date:  2000-04

2.  Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function.

Authors:  M J Drake; I W Mills; J I Gillespie
Journal:  Lancet       Date:  2001-08-04       Impact factor: 79.321

3.  Functional characteristics of urinary tract smooth muscles in mice lacking cGMP protein kinase type I.

Authors:  K Persson; R K Pandita; A Aszòdi; M Ahmad; A Pfeifer; R Fässler; K E Andersson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-09       Impact factor: 3.619

4.  Noncholinergic penile erection in mice lacking the gene for endothelial nitric oxide synthase.

Authors:  Arthur L Burnett; Alex G Chang; Julie K Crone; Paul L Huang; Sena E Sezen
Journal:  J Androl       Date:  2002 Jan-Feb

5.  Effect of intravesical nitric oxide therapy on cyclophosphamide-induced cystitis.

Authors:  H Ozawa; M B Chancellor; S Y Jung; T Yokoyama; M O Fraser; Y Yu; W C de Groat; N Yoshimura
Journal:  J Urol       Date:  1999-12       Impact factor: 7.450

6.  Intravesical oxyhemoglobin initiates bladder overactivity in conscious, normal rats.

Authors:  R K Pandita; H Mizusawa; K E Andersson
Journal:  J Urol       Date:  2000-08       Impact factor: 7.450

7.  Influence of nitric oxide signalling pathways on pre-contracted human detrusor smooth muscle in vitro.

Authors:  Annick Moon
Journal:  BJU Int       Date:  2002-06       Impact factor: 5.588

8.  Beta-adrenoceptor agonists stimulate endothelial nitric oxide synthase in rat urinary bladder urothelial cells.

Authors:  Lori A Birder; Michele L Nealen; Susanna Kiss; William C de Groat; Michael J Caterina; Edward Wang; Gerard Apodaca; Anthony J Kanai
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

9.  The non specificity of specific nitric oxide synthase inhibitors.

Authors:  D A Peterson; D C Peterson; S Archer; E K Weir
Journal:  Biochem Biophys Res Commun       Date:  1992-09-16       Impact factor: 3.575

10.  Nitric oxide and relaxation of pig lower urinary tract.

Authors:  K Persson; K E Andersson
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

View more
  2 in total

1.  NO-Releasing Nanoparticles Ameliorate Detrusor Overactivity in Transgenic Sickle Cell Mice via Restored NO/ROCK Signaling.

Authors:  Serkan Karakus; Biljana Musicki; Mahantesh S Navati; Joel M Friedman; Kelvin P Davies; Arthur L Burnett
Journal:  J Pharmacol Exp Ther       Date:  2020-03-06       Impact factor: 4.030

Review 2.  Nanotechnology as a tool to advance research and treatment of non-oncologic urogenital diseases.

Authors:  Justin Loloi; Mustufa Babar; Kelvin P Davies; Sylvia O Suadicani
Journal:  Ther Adv Urol       Date:  2022-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.